Dennis Kleid is the co-creator of the first genetically engineered human insulin. His journey from a dyslexic kid to a pioneering scientist at Genentech is a testament to imagination, determination, and the power of seeing the world differently
[Premium] Sorting Out the Differences Between Dyslexia and ADD / ADHD
On one level, Dyslexia and ADD / ADHD would seem quite different, but in reality, we are only at the beginning of our understanding of how the two might overlap and be different. Both Dyslexia and ADD / ADHD were initially characterized by their negatives – Dyslexia by difficulty learning to read, and ADD / ADHD by difficulty paying attention. Today we know that for both, positive qualities like higher levels of creativity and ability can be associated as well as negatives, and researchers are only now beginning to take a more careful look at what these two designations imply. For those who don’t know, as a group, children with ADD / ADHD score lower on many tests of phonology and reading comprehension, theoretically because of their […]
Critical Review of the Use of Strattera on Healthy Children with Dyslexia
In a controversial paper, Dr. Sally Shaywitz and colleagues at the Yale Center for Dyslexia and Creativity and the Eli Lilly Pharmaceutical Company have authored a paper that examines the effect of the norephinephrine uptake inhibitor Atomoxetine (Strattera) on...
